These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial. Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD Trials; 2023 May; 24(1):320. PubMed ID: 37161488 [TBL] [Abstract][Full Text] [Related]
6. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial. Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130 [TBL] [Abstract][Full Text] [Related]
7. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Walker E; Osborn DA Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182 [TBL] [Abstract][Full Text] [Related]
8. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews. van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338 [TBL] [Abstract][Full Text] [Related]
9. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D and bronchopulmonary dysplasia in preterm infants. Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562 [TBL] [Abstract][Full Text] [Related]
11. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants. Chen X; Li H; Qiu X; Yang C; Walther FJ BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810 [TBL] [Abstract][Full Text] [Related]
12. Trends in Bronchopulmonary Dysplasia Among Extremely Preterm Infants in Japan, 2003-2016. Nakashima T; Inoue H; Sakemi Y; Ochiai M; Yamashita H; Ohga S; J Pediatr; 2021 Mar; 230():119-125.e7. PubMed ID: 33246013 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary Gas Exchange Improves over the First Year in Preterm Infants with and without Bronchopulmonary Dysplasia. Choi YJ; Stoecklin B; Hemy NR; Hall GL; Doherty DA; Simpson SJ; Pillow JJ Neonatology; 2021; 118(1):98-105. PubMed ID: 33592606 [TBL] [Abstract][Full Text] [Related]
14. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD; JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753 [TBL] [Abstract][Full Text] [Related]
15. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants. Dolma K; Zayek M; Gurung A; Eyal F Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780 [TBL] [Abstract][Full Text] [Related]
16. Capillary partial pressure of carbon dioxide for predicting rehospitalization in preterm infants under noninvasive respiratory support with severe bronchopulmonary dysplasia. Shin SH; Shin JS; Kim EK; Kim HS Pediatr Pulmonol; 2021 Dec; 56(12):3863-3869. PubMed ID: 34547833 [TBL] [Abstract][Full Text] [Related]
17. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562 [TBL] [Abstract][Full Text] [Related]
18. Association between plasma lysophosphatidic acid levels and bronchopulmonary dysplasia in extremely preterm infants: A prospective study. Li H; Huang Z; Yang C; Han D; Wang X; Qiu X; Zhang Z; Chen X Pediatr Pulmonol; 2023 Dec; 58(12):3516-3522. PubMed ID: 37712600 [TBL] [Abstract][Full Text] [Related]
19. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants. Lal CV; Olave N; Travers C; Rezonzew G; Dolma K; Simpson A; Halloran B; Aghai Z; Das P; Sharma N; Xu X; Genschmer K; Russell D; Szul T; Yi N; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515035 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial. Abounahia FF; Abu-Jarir R; Abounahia MF; Al-Badriyeh D; Abushanab D; Abu-Ghalwa M; Mansour A; Kurdi B; Al-Rifai H Clin Drug Investig; 2019 Nov; 39(11):1093-1107. PubMed ID: 31414269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]